ReviewSaudi journal of biological sciences2020
Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response.
Review in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 60 citations in OpenAlex.
- Occupational stress, job satisfaction, and intention to leave among critical care nurses during the COVID-19 pandemic: a cross-sectional study in Lebanon.Frontiers in public health · 2026Article
- Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.Inflammopharmacology · 2024Review
- Radiological changes in the thymus in patients who have had COVID-19 and in vaccinated persons who have not had COVID-19: a CT study.Radiologie (Heidelberg, Germany) · 2024Article
- SARS-CoV-2 Infection in Venezuelan Pediatric Patients-A Single Center Prospective Observational Study.Biomedicines · 2023Article
- Identification of Suitable Drug Combinations for Treating COVID-19 Using a Novel Machine Learning Approach: The RAIN Method.Life (Basel, Switzerland) · 2022Review
- Thymus Gland: A Double Edge Sword for Coronaviruses.Vaccines · 2021Review
- Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies.Saudi journal of biological sciences · 2021Article
- Diffuse functional brain disconnection syndrome in critically ill patients with COVID-19.Journal of infection and public health · 2021Article
- Nano-therapeutic strategies to target coronavirus.View (Beijing, China) · 2021Review
- Efficacy of High-Dose Nebulized Interferon α 2b in Severe COVID-19 Pneumonia.Turkish thoracic journal · 2021Article
- Review
- Wide spectrum of clinical picture of COVID-19 in children - From mild to severe disease.Journal of infection and public health · 2021Article
- Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.The Journal of general virology · 2021Article
- Aging in COVID-19: Vulnerability, immunity and intervention.Ageing research reviews · 2021Review
- Can secondary lymphoid organs exert a favorable effect on the mild course of COVID-19 in children?Acta oto-laryngologica · 2021Article
- SARS-CoV-2 persistence and non-protective immunity in infected haematological patients.British journal of haematology · 2021Article
- Infection-Associated Thymic Atrophy.Frontiers in immunology · 2021Review
- COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome.Journal of infection and public health · 2020Review
- Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children.Journal of infection and public health · 2020Review
- From SARS to COVID-19: What lessons have we learned?Journal of infection and public health · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 pandemic caused by SARS-CoV-2, continues to manifest with severe acute respiratory syndrome among the adults, however, it offers a convincing indication of less severity and fatality in pediatric age group (0-18 years). The current trend suggests that children may get infected but are less symptomatic with less fatality, which is concordant to earlier epidemic outbreaks of SARS-CoV and MERS-CoV, in 2002 and 2012, respectively. According to the available data, children appear to be at lower risk for COVID-19, as adults constitute for maximum number of the confirmed cases (308,592) and deaths (13,069) as on 22nd March (https://www.worldometers.info/coronavirus). However, rapid publications and information of the adult patients with COVID-19 is in progress and published, on the contrary, almost no comprehensive data or discussion about the COVID-19 in children is available. Therefore, in this review, we outline the epidemiology, clinical symptoms, diagnosis, treatment, prevention, possible immune response and role of thymus in children to combat the COVID-19 outbreak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.